Vanda Pharmaceuticals
VNDA
#7861
Rank
$0.31 B
Marketcap
$5.39
Share price
3.65%
Change (1 day)
11.36%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Net assets

Net assets on the balance sheet as of September 2025 : $0.46 Billion USD

According to Vanda Pharmaceuticals's latest financial reports the company has $0.46 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Vanda Pharmaceuticals - Net assets on balance sheet (from 2005 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$$0.53 B-1.17%
2023-12-31$$0.54 B3.36%
2022-12-31$$0.52 B4.41%
2021-12-31$$0.50 B11.4%
2020-12-31$$0.45 B10.3%
2019-12-31$$0.41 B49.21%
2018-12-31$$0.27 B109.63%
2017-12-31$$0.13 B0.04%
2016-12-31$$0.13 B-1.28%
2015-12-31$$0.13 B-17.28%
2014-12-31$$0.16 B264.47%
2013-12-31$$44.12 M345.47%
2012-12-31$$9.9 M-70.41%
2011-12-31$$33.47 M-11.28%
2010-12-31$$37.73 M63.83%
2009-12-31$$23.03 M-49.95%
2008-12-31$$46.02 M-45.04%
2007-12-31$$83.72 M212.92%
2006-12-31$$26.75 M-12.74%
2005-12-31$$30.66 M92.33%
2004-12-31$$15.94 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
$44.75 B 9,503.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
$23.85 B 5,018.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$79.27 B 16,912.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$18.60 B 3,891.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$93.09 B 19,877.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
$2.78 M-99.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$51.90 B 11,038.87%๐Ÿ‡บ๐Ÿ‡ธ USA